| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/03/2002 | EP1192268A2 Nucleic acid binding of multi-zinc finger transcription factors |
| 04/03/2002 | EP1192259A1 Tankyrase2 materials and methods |
| 04/03/2002 | EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods |
| 04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
| 04/03/2002 | EP1192253A1 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
| 04/03/2002 | EP1192249A1 47 human secreted proteins |
| 04/03/2002 | EP1192185A2 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM |
| 04/03/2002 | EP1192181A1 Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor |
| 04/03/2002 | EP1192179A2 Compound derived from an offset orf of the ice gene |
| 04/03/2002 | EP1192171A1 48 human secreted proteins |
| 04/03/2002 | EP1192162A2 Taxane derivatives and processes for the preparation thereof |
| 04/03/2002 | EP1192158A2 Substituted 8-phenylxanthines useful as antagonists of a 2b? adenosine receptors |
| 04/03/2002 | EP1192151A1 Anilinoquinazolines as protein tyrosine kinase inhibitors |
| 04/03/2002 | EP1192150A1 New pharmaceutically active compounds |
| 04/03/2002 | EP1192147A1 Mycolactone and related compounds, compositions and methods of use |
| 04/03/2002 | EP1192144A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids |
| 04/03/2002 | EP1192141A1 1,4-diazacycloheptane derivatives as neuroprotective agents |
| 04/03/2002 | EP1192132A2 Serine protease inhibitors |
| 04/03/2002 | EP1192122A1 Benzene derivatives, preparation method and pharmaceutical compositions containing same |
| 04/03/2002 | EP1191975A2 Improvement of t cell mediated immunity |
| 04/03/2002 | EP1191948A2 High dose radionuclide complexes for bone marrow suppression |
| 04/03/2002 | EP1191944A2 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES |
| 04/03/2002 | EP1191941A1 A method for the prophylaxis and/or treatment of medical disorders |
| 04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
| 04/03/2002 | EP1191938A2 Immunity generation |
| 04/03/2002 | EP1191931A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 04/03/2002 | EP1162201A9 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 04/03/2002 | EP1161240A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1082330B1 Platinum complex, its preparation and therapeutic application |
| 04/03/2002 | EP1007512B1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors |
| 04/03/2002 | EP0983221B1 Cyclohexanediol derivatives |
| 04/03/2002 | EP0929552B1 Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives |
| 04/03/2002 | EP0894092B1 A cyclic hepta-peptide derivative from colonial ascidians, lissoclinum sp. |
| 04/03/2002 | EP0883627B1 Radionuclide labeling of vitamin b12 and coenzymes thereof |
| 04/03/2002 | EP0874645B1 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics |
| 04/03/2002 | EP0865440B1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 04/03/2002 | EP0856051B1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 04/03/2002 | EP0726941B1 Methods for (ex vivo) therapy using peptide-loaded antigen presenting cells for the activation of ctl |
| 04/03/2002 | EP0722489B1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 04/03/2002 | EP0666868B1 Use of anti-VEGF antibodies for the treatment of cancer |
| 04/03/2002 | CN1343221A Polypeptide variants with altered effector function |
| 04/03/2002 | CN1343220A Method for producing cyclo-(Asp-Dphe-NMeval-Arg-Gly) |
| 04/03/2002 | CN1343214A L-arabino-disaccharides of anthracyclines, processes for their preparation, and pharmaceutical compositions containing them |
| 04/03/2002 | CN1343209A Camptothecin derivatives having antitumor activity |
| 04/03/2002 | CN1343206A Cyclocompound |
| 04/03/2002 | CN1343201A Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
| 04/03/2002 | CN1343127A Potentiation of anti-CD38-immunotoxin cytotoxicity |
| 04/03/2002 | CN1343125A Immunostimulant bacterial membrane tractions in cancer treatment |
| 04/03/2002 | CN1343124A Bacterial membrane fractions with adjuvant effect |
| 04/03/2002 | CN1343122A Remedies for joint diseases |
| 04/03/2002 | CN1343118A Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 04/03/2002 | CN1342657A Compound extracted from manatee for suppressing generation of new blood vessel in tumor |
| 04/03/2002 | CN1342656A Cyclobornane triterpenoid saponin compound and its application in immunosuppresion and treating tumor |
| 04/03/2002 | CN1342654A C21 steriod glycoside extracted from white fleece flower root with antineoplastic function |
| 04/03/2002 | CN1342653A 1,6-fructostrontium biphosphate compounds and their preparing process and medical application |
| 04/03/2002 | CN1342493A IL6/IL2 fusion protein method for inducing differentiation of chronic granulocytic leukemia |
| 04/03/2002 | CN1342471A Antalgic Bingchan ointment and its preparing process |
| 04/03/2002 | CN1342459A Medicine for treating solid tumor by injection |
| 04/03/2002 | CN1082091C Recombination human tumour necrofactor and preparation method |
| 04/03/2002 | CN1081928C Preparation of medicine for curing burns and scalds |
| 04/03/2002 | CN1081927C Wolfberry powder and production method thereof |
| 04/03/2002 | CN1081926C Chinese medicine for preventing tumour and its preparation method |
| 04/03/2002 | CN1081917C Medicine composition for deep tumor by local treatment, and using same in pharmaceutic |
| 04/02/2002 | USRE37623 Enzyme inhibitors, their synthesis, and methods for use |
| 04/02/2002 | US6365768 Interleukin-1 and tumor necrosis factors-α modulators, syntheses of said modulators and methods of using modulators |
| 04/02/2002 | US6365759 Intermediate compounds for preparing macrocylcic analogs |
| 04/02/2002 | US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 04/02/2002 | US6365664 Gels formed by the interaction of poly(aldehyde) with various substances |
| 04/02/2002 | US6365627 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |
| 04/02/2002 | US6365588 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/02/2002 | US6365583 Methods to enhance white blood cell count |
| 04/02/2002 | US6365577 Administering to the subject, in a suitable pharmaceutical carrier, a pharmaceutically effective amount of an antisense agent which is morpholino oligonucleotide for inhibiting expression of p53 |
| 04/02/2002 | US6365572 For therapy of diseases related to increased or unwanted synthesis of basement membranes such as diabetes mellitus; atherosclerosis; cancer; diabetic retinopathia; fibroplasia retrolentalis; or psoriasis, rheumatoic arthritis |
| 04/02/2002 | US6365571 FGF inhibitor, angiogenesis inhibitor and antitumor agent containing complestatin or its derivative as effective ingredient |
| 04/02/2002 | US6365402 Growth differentiation factor-9 |
| 04/02/2002 | US6365391 Isolated human serine protease, nucleic acid molecules encoding human serine protease, and uses thereof |
| 04/02/2002 | US6365371 Amino acid sequence; diagnosis, prevention and treatment of cancer, reproductive disorders, immune disorders, and developmental disorders; anticarcinogenic agents |
| 04/02/2002 | US6365358 Polypeptide of defined amino acid sequence; diagnosis, prevention and treatment of cancer, developmental, autoimmune and nervous system disorders; anticarcinogenic agents; antiinflammatory agents |
| 04/02/2002 | US6365351 Non-invasive method for detecting target RNA |
| 04/02/2002 | US6365345 Antisense nucleic acids for the prevention and treatment of disorders in which expression of c-erbB plays a role |
| 04/02/2002 | US6365179 Conjugate having a cleavable linkage for use in a liposome |
| 04/02/2002 | CA2357925A1 Prophylactic use of n-methyl-d-asparate (nmda) antagonists |
| 04/02/2002 | CA2056066C A physical form of n-[4-[5-(cyclopentyloxycarbony)amino-1-methylindol-3yl-methy1]-3-methoxybenzoy1]-2-methlbenzenesulphonamide, processes for its preparation and compositions containing it |
| 03/29/2002 | WO2003045398A1 Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 03/29/2002 | WO2002066039A1 Anticancer agent |
| 03/28/2002 | WO2002025285A1 Prognostic indicator |
| 03/28/2002 | WO2002024947A2 Cancer associated protein kinases and their uses |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024923A1 Polypeptide having phospholipase a2 actiivty |
| 03/28/2002 | WO2002024912A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | WO2002024909A2 Receptor nucleic acids and polypeptides |
| 03/28/2002 | WO2002024897A2 Conditionally replicating viral vectors and their use |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024887A2 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 03/28/2002 | WO2002024754A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 03/28/2002 | WO2002024745A2 Method for detecting tumor cells |
| 03/28/2002 | WO2002024733A2 Human polynucleotides and polypeptides encoded thereby |
| 03/28/2002 | WO2002024717A1 Antisense modulation of flip-c expression |